Targeting children of substance-using parents with the community-based group intervention TRAMPOLINE: a randomised controlled trial--design, evaluation, recruitment issues.

Standard

Targeting children of substance-using parents with the community-based group intervention TRAMPOLINE: a randomised controlled trial--design, evaluation, recruitment issues. / Bröning, Sonja; Wiedow, Annika; Wartberg, Lutz; Ruths, Sylvia; Haevelmann, Andrea; Kindermann, Sally-Sophie; Moesgen, Diana; Schaunig-Busch, Ines; Klein, Michael; Thomasius, Rainer.

In: BMC PUBLIC HEALTH, Vol. 12, 2012, p. 223.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{bc5867bd466a4f03a0a8cf9f14f2b892,
title = "Targeting children of substance-using parents with the community-based group intervention TRAMPOLINE: a randomised controlled trial--design, evaluation, recruitment issues.",
abstract = "Children of substance-abusing parents are at risk for developing psychosocial development problems. In Germany it is estimated that approx. 2.65 million children are affected by parental substance abuse or dependence. Only ten percent of them receive treatment when parents are treated. To date, no evaluated programme for children from substance-affected families exists in Germany. The study described in this protocol is designed to test the effectiveness of the group programme TRAMPOLINE for children aged 8-12 years with at least one substance-abusing or -dependent caregiver. The intervention is specifically geared to issues and needs of children from substance-affected families.",
keywords = "Adult, Germany, Humans, Male, Female, Adolescent, Child, Population Surveillance, Patient Acceptance of Health Care, Attitude of Health Personnel, Program Evaluation, *Research Design, *Health Knowledge, Attitudes, Practice, *Patient Selection, Family Characteristics, Parents/psychology, Patient Participation, *Child of Impaired Parents, *Community Health Services/methods, Family Practice/*methods/standards, Professional-Family Relations, Stress, Psychological, *Substance-Related Disorders/therapy, Adult, Germany, Humans, Male, Female, Adolescent, Child, Population Surveillance, Patient Acceptance of Health Care, Attitude of Health Personnel, Program Evaluation, *Research Design, *Health Knowledge, Attitudes, Practice, *Patient Selection, Family Characteristics, Parents/psychology, Patient Participation, *Child of Impaired Parents, *Community Health Services/methods, Family Practice/*methods/standards, Professional-Family Relations, Stress, Psychological, *Substance-Related Disorders/therapy",
author = "Sonja Br{\"o}ning and Annika Wiedow and Lutz Wartberg and Sylvia Ruths and Andrea Haevelmann and Sally-Sophie Kindermann and Diana Moesgen and Ines Schaunig-Busch and Michael Klein and Rainer Thomasius",
year = "2012",
doi = "10.1186/1471-2458-12-223",
language = "English",
volume = "12",
pages = "223",
journal = "BMC PUBLIC HEALTH",
issn = "1471-2458",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - Targeting children of substance-using parents with the community-based group intervention TRAMPOLINE: a randomised controlled trial--design, evaluation, recruitment issues.

AU - Bröning, Sonja

AU - Wiedow, Annika

AU - Wartberg, Lutz

AU - Ruths, Sylvia

AU - Haevelmann, Andrea

AU - Kindermann, Sally-Sophie

AU - Moesgen, Diana

AU - Schaunig-Busch, Ines

AU - Klein, Michael

AU - Thomasius, Rainer

PY - 2012

Y1 - 2012

N2 - Children of substance-abusing parents are at risk for developing psychosocial development problems. In Germany it is estimated that approx. 2.65 million children are affected by parental substance abuse or dependence. Only ten percent of them receive treatment when parents are treated. To date, no evaluated programme for children from substance-affected families exists in Germany. The study described in this protocol is designed to test the effectiveness of the group programme TRAMPOLINE for children aged 8-12 years with at least one substance-abusing or -dependent caregiver. The intervention is specifically geared to issues and needs of children from substance-affected families.

AB - Children of substance-abusing parents are at risk for developing psychosocial development problems. In Germany it is estimated that approx. 2.65 million children are affected by parental substance abuse or dependence. Only ten percent of them receive treatment when parents are treated. To date, no evaluated programme for children from substance-affected families exists in Germany. The study described in this protocol is designed to test the effectiveness of the group programme TRAMPOLINE for children aged 8-12 years with at least one substance-abusing or -dependent caregiver. The intervention is specifically geared to issues and needs of children from substance-affected families.

KW - Adult

KW - Germany

KW - Humans

KW - Male

KW - Female

KW - Adolescent

KW - Child

KW - Population Surveillance

KW - Patient Acceptance of Health Care

KW - Attitude of Health Personnel

KW - Program Evaluation

KW - Research Design

KW - Health Knowledge, Attitudes, Practice

KW - Patient Selection

KW - Family Characteristics

KW - Parents/psychology

KW - Patient Participation

KW - Child of Impaired Parents

KW - Community Health Services/methods

KW - Family Practice/methods/standards

KW - Professional-Family Relations

KW - Stress, Psychological

KW - Substance-Related Disorders/therapy

KW - Adult

KW - Germany

KW - Humans

KW - Male

KW - Female

KW - Adolescent

KW - Child

KW - Population Surveillance

KW - Patient Acceptance of Health Care

KW - Attitude of Health Personnel

KW - Program Evaluation

KW - Research Design

KW - Health Knowledge, Attitudes, Practice

KW - Patient Selection

KW - Family Characteristics

KW - Parents/psychology

KW - Patient Participation

KW - Child of Impaired Parents

KW - Community Health Services/methods

KW - Family Practice/methods/standards

KW - Professional-Family Relations

KW - Stress, Psychological

KW - Substance-Related Disorders/therapy

U2 - 10.1186/1471-2458-12-223

DO - 10.1186/1471-2458-12-223

M3 - SCORING: Journal article

VL - 12

SP - 223

JO - BMC PUBLIC HEALTH

JF - BMC PUBLIC HEALTH

SN - 1471-2458

ER -